484
I. Piras et al. / Journal of Organometallic Chemistry 695 (2010) 479–486
452([M+],100), 399(2.69), 371(7.45), 329(2.65), 292(73.87),
274(14.81), 205(6.47), 165(6.87), 91(9.77), 69(13.63), 43(14.00);
HR-MS: (calc.) 513.90942, (found) 513.910640 for C20H18O2
Br2Cl1P1.
NMR (300 MHz, CD2Cl2): d (ppm) = 8.03 (s, 1H, arom.), 8.00 (s, 1H,
arom.), 7.94–7.89 (m, arom.), 7.88 (s, 1H, arom.), 7.85 (s, 1H,
arom.), 7.45–7.43 (m, arom.), 7.43–7.41 (m, 1H, arom.), 7.39 (s,
1H, arom.), 7.38–7.34 (m, arom.), 7.32–7.25 (m, arom.), 7.20–7.14
(m, arom.), 2.93–2.64 (m, CH2), 2.56–2.37 (m, CH2), 2.14–1.98 (m,
CH2), 177–1.60 (m, CH2), 1.53–1.37 (m, CH2); 13C NMR (75 MHz,
CD2Cl2): d (ppm) = 148.4, 143.5, 143.0, 138.1, 137.1, 136.9, 135.9,
134.1, 133.1, 132.9, 131.7, 131.5, 131.0, 130.3, 128.9, 128.7,
128.4, 127.6, 127.2, 125.8, 125.4, 124.5, 124.2, 123.1, 121.8,
118.2, 113.3, 112.7, 29.2 (2C), 29.1 (2C), 27.9 (2C), 27.7 (2C), 22.7
(4C), 22.5 (2C), 22.5 (2C); MS (70 eV, EI): m/z (%) = 1247 ([M+],
0.35),1169 (3.41), 1082 (0.36), 916 (4.00), 852 (1.34), 750
(100.00), 584 (9.42), 401 (3.62), 315 (11.14), 268 (28.20), 119
(5.66); HR-MS (ESI+-TOF/MS): [M+Na]+ (calc.) 1264.95518, (found)
1264.95262 for C60H48Br4 NaO6P2.
4.1.2. (1S)-2,2’-bis((11bS)-2,6-Dibromo-8,9,10,11,12,13,14,15-octahy
drodinaphtho[2,1-d:1’,2’-f][1,3,2]dioxaphosphepin-4-yloxy)-5,5’,6,6’,
7,7’,8,8’-octahydro-1,1’-binaphthyl 3
A solution of (S)-H8-binaphthol 1b (1.3 mmol), Et3N (3 mmol)
and DMAP (0.3 mmol) in toluene (20 ml) was added slowly to a
solution of the corresponding phosphoruschloridite 2 (2.63 mmol)
at 0 °C and this temperature was kept for 1 h. The reaction mixture
was stirred overnight and then filtered through a sintered glass
funnel. Evaporation of the solvent gave white foam.
Yield = >99%; (purity = >97%). 31P NMR (162 MHz, C6D6): d
(ppm) = 138.3; 1H NMR (400 MHz, C6D6):
d (ppm) = 7.79 (d,
J = 8.3, 2H, H8-BINOL), 7.20 (s, 2H, Br2–H8-BINOL), 7.09(s, 2H,
Br2–H8-BINOL), 6.98 (d, J = 8.3, 2H, H8-BINOL), 2.72–2.55 (m, 6H,
3CH2), 2.44–2.24 (m, 12H, 6CH2), 2.22–2.10 (m, 2H, CH2), 2.02–
1.86 (m, 4H, 2CH2), 1.62–1.49 (m, 6H, 3CH2), 1.49–1.30 (m, 14H,
7CH2), 1.29–1.05 (m, 4H, 2CH2); 13C NMR (100.6 MHz, C6D6): d
(ppm) = 147.9 (t, J(P,C) = 4.8, 2C), 144.5 (t, J(P,C) = 2.1, 2C), 143.9
(t, J(P,C) < 1, 2C), 137.9 (2C), 137.4 (2C), 136.6, (2C), 136.0 (2C),
135.1 (2C), 134.1 (2C), 133.3 (J(C,H) = 162 Hz, 2CH), 133.1
(J(C,H) = 163 Hz, 2CH), 131.4 (t, J(P,C) = 2.4, 2C), 129.8 (2CH),
129.3 (t, J(P,C) < 1, 2C), 129.0 (t, J(P,C) = 1.4, 2C), 119.1 (t,
J(P,C) = 5.2, 2CH), 114.1 (d, 2C, J(P,C) = 1.3), 113.7 (2C), 29.9
(2CH2), 28.9 (2CH2), 28.9 (2CH2), 28.1 (t, J(P,C) = 2.0, 2CH2), 27.8
(2CH2), 27.6 (2CH2), 23.3 (2CH2), 23.2 (2CH2), 22.6 (2CH2), 22.5
(4CH2), 22.4 (2CH2); MS (70 eV, EI): m/z (%) = 1254 ([M+], 0.56),
1175 (4.02), 1095 (1.24), 760 (17.39), 759 (48.46), 757 (100.00),
755 (44.88), 677 (7.34), 482 (7.34), 401 (8.62), 323 (17.65); HR-
MS: [M+Na]+ (calc.) 1273.01778, (found) 1273.01636; [M+K]+ (cal-
culated) 1288.99172, (found) 1288.99114 for C60H56Br4 O6P2.
4.1.5. (11bS)-2,6-Dibromo-4-((S)-3,3’-dibromo-2’-(dibenzo[d,f][1,3,2]
dioxaphosphepin-6-yloxy)-5,5’,6,6’,7,7’,8,8’-octahydro-1,1’-binaph
thyl-2-yloxy)-8,9,10,11,12,13,14,15-octahydrodinaphtho[2,1-d:1’,2’-
f][1,3,2]dioxaphosphepine 6
Treatment of chlorophosphite 2 and 2,20-dihydroxybiphenyl as
described for compound 3, afforded a mixture of bisphosphites as
a white powder. The compound 6 was isolated by precipitation in
Et2O. Isolated yield = 70%; 31P NMR (162 MHz, CD2Cl2):
d
(ppm) = 142.7 (d, J(P, P) = 50, 1P), 137.0 (d, J(P, P) = 50, 1P); 1H
NMR (400 MHz, CD2Cl2): d (ppm) = 7.58 (s, 1H, Br2–H8-BINOL),
7.47 ꢀ7.45 (m, 1H, Ph), 7.45–7.42 (m, 1H, Ph), 7.39–7.32 (m, 2H,
Ph), 7.30 (s, 2H, Br2–H8-BINOL and Ph), 7.28–7.27 (m, 1H, Ph),
7.26 (s, 1H, Br2–H8-BINOL), 7.22 (s, 1H, Br2–H8-BINOL), 7.14 (dt,
J = 8.0, J = 1.04, 1H, Ph), 6.86 (dt, J = 8.0, J = 1.0, 1H, Ph), 2.85–2.33
(m, 12H, 6CH2), 2.23–2.89 (m, 4H, 2CH2), 1.84–1.34 (m, 16H,
8CH2); 13C NMR (100.6 MHz, CD2Cl2): d (ppm) = 150.0 (d, C, J(P,
C) = 7.3, Ph), 149.0 (d, J(P, C) = 3.2, C, Ph), 146.4 (C), 144.9 (d, J(P,
C) = 6.8, C), 144.0 (d, J(P, C) = 5.0, C), 143.3 (d, J(P, C) = 2.8, C),
138.5 (C), 137.9 (d, J(P, C) = 1.6, C), 137.3 (C), 137.0 (C), 136.7 (d,
J(P, C) = 1.2, C), 136.2 (C), 135.7 (d, J(P, C) < 1, C), 135.3 (d, J(P,
C) < 1, C), 134.2 (CH), 133.4 (CH), 133.1 (CH), 133.0 (CH), 131.9
(d, JPC = 3.6, C, Ph), 130.9 (d, J(P, C) = 5.3, C), 130.8 (d, J(P, C) = 2.5,
C, Ph), 130.2 (C), 130.0 (CH, Ph), 129.9 (CH, Ph), 129.7 (d, J(P,
C) = 4.3, C),129.54 (CH, Ph),129.5 (d, J(P, C) < 2, C), 129.3 (CH, Ph),
128.5 (C), 125.8 (CH, Ph), 125.4 (CH, Ph), 123.1 (CH, Ph), 122.6 (d,
J(P, C) = 1.6, CH, Ph), 113.4 (d, J(P, C) = 2.6, C), 113.1 (C), 112.,7 (d,
J(P, C) = 5.0, C), 111.7 (d, C, J(P, C) = 2.5), 29.8 (CH2), 29.6 (CH2),
29.3 (CH2), 29.2 (CH2), 28.0 (CH2), 27.8 (CH2), 27.8 (CH2), 27.5
(CH2), 23.0 (CH2), 22.9 (CH2), 22.8 (2CH2), 22.8 (CH2), 22.7 (CH2),
22.7 (CH2), 22.6 (CH2). MS (70 eV, EI): m/z (%) = 1146 ([M+], 1.69),
1067 (10.70), 915 (36.47), 649 (100.00), 481 (13.16), 355 (15.71),
281 (16.79), 215 (29.13), 168 (30.25), 131 (18.00), 69 (62.55);
HR-MS (ESI+-TOF/MS): [M+Na]+ (calc.) 1164.92388, (found)
1164.92199; [M+K]+ (calc.) 1180.89782, (found) 1180.89876 for
C52H44Br4O6P2.
4.1.3. (11bS,11b’S)-4,4’-((S)-3,3’-Dibromo-5,5’,6,6’,7,7’,8,8’-octahydro
-1,1’-binaphthyl-2,2’-diyl)bis(oxy)bis(2,6-dibromo-8,9,10,11,12,13,
14,15-octahydrodinaphtho[2,1-d:1’,2’-f][1,3,2]dioxaphosphepine) 4
Treatment of chlorophosphite 2 and 1c, as described for com-
pound 3, afforded the bisphosphite
4 as a white powder.
Yield = >99% (purity = >94%). 31P NMR (121.5 MHz, CDCl3):
d
(ppm) = 137.0; 1H NMR (300 MHz, CDCl3): d (ppm) = 7.27 (s, 2H,
arom.), 7.24 (s, 2H, arom.), 7.15 (s, 2H, arom.), 2.85–2.67 (m, 8H,
4CH2), 2.65–2.39 (m, 8H, 4CH2), 2.35–2.07 (m, 6H, 3CH2), 2.03–
1.89 (m, 2H, CH2), 1.86–1.65 (m, 12H, 6CH2), 1.86–1.24 (m, 12H,
6CH2); 13C NMR (75 MHz, CDCl3): d (ppm) = 144.7 (m, 2C), 144.1
(m, 2C), 143.2 (2C), 137.2 (2C), 137.2 (2C), 136.4 (2C), 135.9 (2C),
134.9 (2C), 134.8 (2C), 132.9 (2CH), 132.9 (2CH), 132.8 (2CH),
130.7 (m, 2C), 130.6 (2C), 129.3 (2C), 113.8 (2C), 113.2 (2C),
112.2 (2C), 29.3 (2C), 29.1 (2C), 29.0 (2C), 27.9 (2C), 27.6 (4C),
22.7 (2C), 22.6 (4C), 22.6 (2C), 22.6 (2C), 22.4 (2C); MS (70 eV,
EI): m/z (%) = 1412 ([M+], 0.78), 1334 (3.70), 1254 (1.55), 1174
(2.82), 917 (69.86), 915 (100.00), 911 (18.84), 481 (18.45); HR-
MS: [M+Na]+ (calc.) 1434.83267, (found) 1434.83466 for
C60H54(79Br)3(81Br)3 NaO6P2.
4.1.6. 2,2’-Bis(8,9,10,11,12,13,14,15-octahydrodinaphtho[2,1-d:1’,2’-
f][1,3,2]dioxaphosphepin-4-yloxy)-5,5’,6,6’,7,7’,8,8’-octahydro-1,1’-
binaphthyl 11
4.1.6.1. Mixture of diastereomers. 31P NMR (162 MHz, CD2Cl2): d
(ppm) = 140.6, 138.8 (d, J(P, P) = 28, 1P), 137.5 (d, J(P, P) = 28, 1P),
138.6, 138.3. MS (70 eV, EI): m/z (%) = 938 ([M+], 2.37), 599
(100.00), 469 (4.44), 323 (19.38), 276 (6.35), 141 (0.81).
4.1.4. (1S)-2,2’-Bis((11bS)-2,6-dibromo-8,9,10,11,12,13,14,15-
octahydrodinaphtho[2,1-d:1’,2’-f][1,3,2]dioxaphosphepin-4-yloxy)-
1,1’-binaphthyl 5
A solution of (S)-BINOL 1a (0.8 mmol), Et3N (1.85 mmol) and
DMAP (0.3 mmol) in Et2O/THF (7/1, 20 ml) was added slowly to a
solution of the corresponding chlorophosphite 2 (1.65 mmol) in
Et2O at 0 °C and this temperature was kept for 1 h. The reaction
mixture was stirred overnight and then filtered through a sintered
glass funnel. Evaporation of the solvent gave white foam mixture.
31P NMR (121.5 MHz, CD2Cl2): d(ppm) = 136.6 (major pick 80%); 1H
4.2. In situ HP-NMR hydroformylation experiment
In a typical experiment, a sapphire tube was filled under Argon
with a solution of Rh(acac)(CO)2 (0.045 mmol) and ligand (molar
ratio PP/Rh = 1.1) in d8-toluene. The HP-NMR tube was pressurized
to 20 bar CO/H2 and afterwards heated to 80 °C.